Form 4: Arcturus Therapeutics Director Exercises Deferred Stock Units and Acquires Stock Options
SEC Form 4 Filing
Director James F. Barlow exercises deferred stock units and acquires stock options in Arcturus Therapeutics Holdings Inc.
Summary
- On June 14, 2024, James F. Barlow, a director of Arcturus Therapeutics Holdings Inc., exercised 3,131 deferred stock units, each equivalent to one share of common stock.
- These units were part of the 2023 annual grant and vested at the company's 2024 annual meeting of stockholders on June 14, 2024.
- Barlow also acquired 15,000 stock options with an exercise price of $31, vesting monthly over one year from the grant date of June 14, 2024, and expiring on June 14, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The director's actions could be interpreted as a positive signal, but it's not definitively bullish.
Positives
- The exercise of deferred stock units and acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly increasing the number of outstanding shares upon exercise of the options and deferred stock units.
Key Dates
| Date | Description |
|---|---|
| August 1, 2023 | Date of the 2023 annual grant of deferred stock units to the Reporting Person. |
| June 14, 2024 | Date of the Issuer's 2024 annual meeting of stockholders, vesting date of the deferred stock units, and transaction date for the exercise of deferred stock units and acquisition of stock options. |
| June 14, 2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.